Cargando…
Safety and Effectiveness of F-18 Fluoroestradiol Positron Emission Tomography/Computed Tomography: a Systematic Review and Meta-analysis
BACKGROUND: We conducted a pooled analysis of the diagnostic accuracy of F-18 fluoroestradiol (F-18 FES) positron emission tomography/computed tomography (PET/CT) assessing estrogen receptor expression of patients who have recurrent or metastatic breast cancer. METHODS: Two investigators and seven r...
Autor principal: | Mo, Jin A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560320/ https://www.ncbi.nlm.nih.gov/pubmed/34725978 http://dx.doi.org/10.3346/jkms.2021.36.e271 |
Ejemplares similares
-
18F-fluoroestradiol positron emission tomography in patients with breast cancer: a systematic review and meta-analysis
por: Matushita, Cristina S., et al.
Publicado: (2023) -
Can (18)F-Fluoroestradiol Positron Emission Tomography Become a New Imaging Standard in the Estrogen Receptor-positive Breast Cancer Patient: A Prospective Comparative Study with (18)F-Fluorodeoxyglucose Positron Emission Tomography?
por: Gupta, Manoj, et al.
Publicado: (2017) -
Comparison of diagnostic sensitivity of [(18)F]fluoroestradiol and [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer
por: Chae, Sun Young, et al.
Publicado: (2020) -
Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy
por: van Kruchten, Michel, et al.
Publicado: (2015) -
Comparison of (18)F-fluorothymidine Positron Emission Tomography/Computed Tomography and (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
por: Mori, Mio, et al.
Publicado: (2022)